Medicare Enrolled
Dr. Arthur Campsey, PA-C
Medical Physician Assistant · Schertz, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Campsey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Campsey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Campsey
Dr. Arthur Campsey is a medical physician assistant in Schertz, TX, with 11 years of NPI registration. Based on federal Medicare data, Dr. Campsey performed 1,972 Medicare services across 942 unique beneficiaries.
Between the years covered by Open Payments, Dr. Campsey received a total of $9,623 from 58 pharmaceutical and/or device companies across 782 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Campsey is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 8% volume in TX
$9,623 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,972
Medicare services
Top 8% in TX for medical physician assistant
942
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~179 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
533 | $68 | $251 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
211 | $8 | $38 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
211 | $34 | $70 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
185 | $5 | $29 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
166 | $30 | $97 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
157 | $30 | $106 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
84 | $101 | $256 |
| Annual depression screening | 74 | $15 | $36 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
61 | $61 | $165 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
40 | $9 | $50 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
24 | $11 | $36 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
22 | $20 | $66 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
22 | $3 | $25 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
21 | $41 | $161 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
17 | $34 | $70 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
17 | $34 | $70 |
| Mycoplasma pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Mycoplasma pneumoniae bacteria. |
16 | $34 | $70 |
| Respiratory virus nucleic acid test, 3-5 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets. |
16 | $140 | $285 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
16 | $8 | $40 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
15 | $50 | $103 |
| Chlamydia pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Chlamydia pneumoniae bacteria in a sample. |
13 | $34 | $70 |
| Enterovirus nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of enteroviruses in a sample. |
13 | $34 | $70 |
| Respiratory syncytial virus (RSV) nucleic acid test A laboratory test that uses nucleic acid amplification to detect the presence of respiratory syncytial virus in a sample. |
13 | $69 | $140 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $54 | $218 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
12 | $34 | $70 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,623
Total received (2021-2024)
Avg $2,406/year across 4 years
Top 5% in TX for medical physician assistant
58
Companies
782
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,623 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,218
2023
$2,841
2022
$2,303
2021
$2,260
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,812
Novo Nordisk Inc
$859
Lilly USA, LLC
$805
Amgen Inc.
$675
AbbVie Inc.
$542
GlaxoSmithKline, LLC.
$340
Janssen Pharmaceuticals, Inc
$319
PFIZER INC.
$308
AstraZeneca Pharmaceuticals LP
$272
Amarin Pharma Inc.
$255
Almatica Pharma LLC
$238
SANOFI-AVENTIS U.S. LLC
$225
Biohaven Pharmaceutical Holding Company Ltd.
$196
Boehringer Ingelheim Pharmaceuticals, Inc.
$191
Takeda Pharmaceuticals U.S.A., Inc.
$163
Bayer Healthcare Pharmaceuticals Inc.
$154
Abbott Laboratories
$153
ITI, Inc.
$152
Paratek Pharmaceuticals, Inc.
$125
Biohaven Pharmaceuticals, Inc.
$121
Daiichi Sankyo Inc.
$114
Dexcom, Inc.
$109
Novartis Pharmaceuticals Corporation
$107
Merck Sharp & Dohme LLC
$107
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$105
Astellas Pharma US Inc
$97
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$89
Medtronic, Inc.
$84
Sumitomo Pharma America, Inc.
$76
Corcept Therapeutics
$61
Kowa Pharmaceuticals America, Inc.
$60
Supernus Pharmaceuticals, Inc.
$57
ABIOMED
$51
Ardelyx, Inc.
$50
Phathom Pharmaceuticals, Inc.
$49
Avanir Pharmaceuticals, Inc.
$40
Axsome Therapeutics, Inc.
$38
Inspire Medical Systems, Inc.
$36
Esperion Therapeutics, Inc.
$36
JAZZ PHARMACEUTICALS INC.
$33
QOL Medical, LLC
$30
Nevro Corp.
$30
Antares Pharma, Inc.
$29
Althera Pharmaceuticals LLC
$22
Lexicon Pharmaceuticals, Inc.
$22
Nestle HealthCare Nutrition Inc.
$19
Teva Pharmaceuticals USA, Inc.
$18
Neos Therapeutics, LP
$17
IDORSIA PHARMACEUTICALS US INC
$17
Noven Therapeutics, LLC
$16
Otsuka America Pharmaceutical, Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$13
Azurity Pharmaceuticals, Inc.
$13
Adlon Therapeutics L.P.
$13
Eisai Inc.
$12
Bausch Health US, LLC
$12
BioDelivery Sciences International, Inc.
$11
Corium, LLC
$10
Top 3 companies account for 36.1% of total payments
Associated products mentioned in payments ›
ADHANSIA XR · AREXVY · AUSTEDO · Adzenys XR-ODT · Aimovig · Auvelity · Azstarys · BELBUCA · BELSOMRA · BREZTRI · CAPLYTA · CREON · DELZICOL · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · GRALISE · IBSRELA · INJECTAFER · INSPIRE · Impella · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · LOREEV XR · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NUCALA · NURTEC ODT · NUZYRA · Nuedexta · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · Proclaim IPG · QELBREE · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · RYBELSUS · Repatha · Roszet · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SUCRAID · SUNOSI · Saxenda · Secuado · Senza · Sunosi · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · VenaSeal · Veozah · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for medical physician assistant in TX.
Equivalent to $488 per 100 Medicare services performed
Geographic Context
Medical physician assistants within 10 mi
295
Per 100K population
14.5
County median income
$70,571
Nearest hospital
LAUREL RIDGE TREATMENT CENTER
11.0 mi
11.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Campsey is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), with low-engagement industry engagement in the top 5% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Campsey experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Campsey performed 533 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Campsey receive payments from pharmaceutical companies?
Yes. Dr. Campsey received a total of $9,623 from 58 companies across 782 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Campsey's costs compare to other medical physician assistants in Schertz?
Dr. Campsey's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Campsey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Physician Assistants in Schertz
Browse medical physician assistants in Schertz ranked by procedure volume and transparency data.
Highest volume
Top Medical Physician Assistants in TX
Medical physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Physician Assistants in TX
Which TX medical physician assistants receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology